MAPT and Alzheimer disease: We have shown previously that pseudophosphorylation at Ser199, Thr212, Thr231, and Ser262 with inclusion of the FTDP-17 R406W mutation (Pathological Human Tau, PH-Tau) results in a protein that mimics the effect of AD P-tau in culture (Alonso et al., 2010).